On October 25, 2017 Vericel Corporation (NASDAQ:VCEL), a leading developer of autologous expanded cell therapies for the treatment of patients with serious diseases and conditions, reported the following webcast and conference call (Press release, Vericel, OCT 25, 2017, View Source [SID1234521174]):

What: Vericel Corporation Third-Quarter 2017 Earnings Call

When: Tuesday, November 7, 2017 at 8:00am (EST)

Where: View Source

How: The conference call will be available live in the Investors section of the Vericel website
at View Source. Please access the site at least 15 minutes prior
to the scheduled start time in order to download the required audio software if necessary.
To participate in the live call by telephone, please call (877) 312-5881 and reference Vericel Corporation third-quarter 2017 investor conference call. If calling from outside the U.S., please use the international phone number (253) 237-1173.

If you are unable to participate in the live call, the webcast will be available at View Source until November 7, 2018. A replay of the call will also be available until 11:00am (EST) on November 11, 2017 by calling (855) 859-2056, or from outside the U.S. (404) 537-3406. The conference ID is 7097908.

On October 25, 2017 Synthetic Biologics, Inc. (NYSE American: SYN), a late-stage clinical company developing therapeutics that preserve the microbiome to protect and restore the health of patients, announced reported that the Company intends to release its operational highlights and financial results for the quarter ended September 30, 2017 on Wednesday, November 1, 2017, and to host a conference call the same day at 4:30 p.m. EDT(Press release, Synthetic Biologics, OCT 25, 2017, View Source [SID1234521177]). The dial-in information for the call is as follows:

U.S. (toll free): 1-888-347-5280
International: +1 412-902-4280

Participants are asked to dial in 15 minutes before the start of the call to register. The call will also be webcast over the Internet at View Source." target="_blank" title="View Source." rel="nofollow">View Source An archived replay of the call will be available for approximately ninety (90) days at the same URL, View Source, beginning approximately one hour after the call’s conclusion.

On October 25, 2017 Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) reported that it will report financial results for the third quarter ended September 30, 2017, after the market close on Wednesday, November 1, 2017 (Press release, Conatus Pharmaceuticals, OCT 25, 2017, View Source [SID1234521178]). Conatus will host a conference call and audio webcast at 4:30 p.m. Eastern Time on Wednesday, November 1, 2017, to discuss the financial results and provide a corporate update.

To access the conference call, please dial 877-312-5857 (domestic) or 970-315-0455 (international) at least five minutes prior to the start time and refer to conference ID 99505370. A live and archived audio webcast of the call will also be available in the Investors section of the Conatus website at www.conatuspharma.com.

On October 25, 2017 Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, reported that it will release its third quarter 2017 financial results on Thursday, November 2, 2017 (Press release, Insmed, OCT 25, 2017, View Source [SID1234521153]).

Insmed management will host a conference call for investors beginning at 8:30 a.m. ET on Thursday, November 2, 2017 to discuss the financial results and provide a business update.

Shareholders and other interested parties may participate in the conference call by dialing (844) 707-0669 (domestic) or (703) 639-1223 (international) and referencing conference ID number 5699819. The call will also be webcast live on the internet on the company’s website at www.insmed.com.

A replay of the conference call will be accessible approximately two hours after its completion through November 9, 2017 by dialing (855) 859-2056 (domestic) or (404) 537-3406 (international) and referencing conference ID number 5699819. A webcast of the call will also be archived for 90 days under the Investor Relations section of the company’s website at www.insmed.com.